ERAS
Price
$2.00
Change
+$0.19 (+10.50%)
Updated
Sep 26, 03:44 PM (EDT)
Capitalization
513.44M
40 days until earnings call
IRON
Price
$65.28
Change
+$2.79 (+4.46%)
Updated
Sep 26, 04:13 PM (EDT)
Capitalization
2.17B
41 days until earnings call
Interact to see
Advertisement

ERAS vs IRON

Header iconERAS vs IRON Comparison
Open Charts ERAS vs IRONBanner chart's image
Erasca
Price$2.00
Change+$0.19 (+10.50%)
Volume$100
Capitalization513.44M
Disc Medicine
Price$65.28
Change+$2.79 (+4.46%)
Volume$450
Capitalization2.17B
ERAS vs IRON Comparison Chart in %
Loading...
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ERAS vs. IRON commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERAS is a StrongBuy and IRON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ERAS: $1.81 vs. IRON: $62.50)
Brand notoriety: ERAS and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERAS: 94% vs. IRON: 69%
Market capitalization -- ERAS: $513.44M vs. IRON: $2.17B
ERAS [@Biotechnology] is valued at $513.44M. IRON’s [@Biotechnology] market capitalization is $2.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERAS’s FA Score shows that 1 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • ERAS’s FA Score: 1 green, 4 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, both ERAS and IRON are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERAS’s TA Score shows that 4 TA indicator(s) are bullish while IRON’s TA Score has 4 bullish TA indicator(s).

  • ERAS’s TA Score: 4 bullish, 4 bearish.
  • IRON’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, IRON is a better buy in the short-term than ERAS.

Price Growth

ERAS (@Biotechnology) experienced а -3.21% price change this week, while IRON (@Biotechnology) price change was -0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +55.19%.

Reported Earning Dates

ERAS is expected to report earnings on Nov 05, 2025.

IRON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($2.17B) has a higher market cap than ERAS($513M). IRON YTD gains are higher at: -1.420 vs. ERAS (-27.888). ERAS (-135.93M) and IRON (-142.42M) have comparable annual earnings (EBITDA) . IRON has more cash in the bank: 650M vs. ERAS (301M). IRON has less debt than ERAS: IRON (30.9M) vs ERAS (49.4M). ERAS (0) and IRON (0) have equivalent revenues.
ERASIRONERAS / IRON
Capitalization513M2.17B24%
EBITDA-135.93M-142.42M95%
Gain YTD-27.888-1.4201,965%
P/E RatioN/AN/A-
Revenue00-
Total Cash301M650M46%
Total Debt49.4M30.9M160%
TECHNICAL ANALYSIS
Technical Analysis
ERASIRON
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 29 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSIAX49.45N/A
N/A
PGIM Quant Solutions Large-Cap Index A
HGXTX16.98-0.14
-0.82%
Hartford Global Impact R5
MKDVX20.90-0.18
-0.85%
BlackRock Equity Dividend K
GLNLX24.26-0.27
-1.10%
MFS Global New Discovery R3
BFGFX50.70-0.58
-1.13%
Baron Focused Growth Retail

ERAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ERAS has been loosely correlated with XNCR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ERAS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERAS
1D Price
Change %
ERAS100%
-5.24%
XNCR - ERAS
55%
Loosely correlated
-1.34%
OCUL - ERAS
54%
Loosely correlated
-2.55%
RVMD - ERAS
50%
Loosely correlated
-2.37%
BEAM - ERAS
50%
Loosely correlated
-2.12%
IRON - ERAS
49%
Loosely correlated
+0.18%
More

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with NUVL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+0.18%
NUVL - IRON
54%
Loosely correlated
-2.54%
SYRE - IRON
52%
Loosely correlated
-8.18%
CGON - IRON
51%
Loosely correlated
-0.55%
XNCR - IRON
50%
Loosely correlated
-1.34%
CRNX - IRON
50%
Loosely correlated
+2.02%
More